Delta-8 THC and THC-O: How Federal Law and Safety Concerns Differ
Delta-8 vs. THC-O: how federal hemp rules, safety concerns, and upcoming law changes reshape legality and consumer risk.
Articles
Cannabinoids for Epidermolysis Bullosa: Early Signals, Limited Evidence
Cannabinoid-based therapies for epidermolysis bullosa show early signals but limited evidence; learn what small studies and safety concerns mean for patients.
Cannabis Is Not a Proven Alternative Treatment for Depression
Cannabis is not a proven depression treatment: learn what recent reviews say, safety risks with antidepressants, and smarter, evidence-based options.
Delta-8 and Delta-9 THC: Similar Chemistry, Different Potency and Risks
Delta-8 vs Delta-9 THC: learn how tiny chemical differences affect potency, safety, and legality—and what to know before using or buying.
CBD Flower Risks: What Users Should Know About Drug Interactions, Smoke Exposure and Product Quality
CBD flower safety: learn how drug interactions, breathing risks from smoking, and inconsistent product quality could affect you—before you use.
Cannabis and Thyroid Disease: What the Evidence Actually Shows
Cannabis, CBD, and thyroid disease: what the evidence really shows—no proven treatment, safety tips, and why medical guidance matters.
Cannabis Use Disorder Linked to Slightly Shorter Hospital Stays After Hip and Knee Replacement
Can cannabis use disorder affect recovery after hip or knee replacement? A large study hints shorter hospital stays but it cautions against assuming benefits.
Cannabis for Postherpetic Neuralgia: What the Evidence Shows
What does the evidence say about cannabis for postherpetic neuralgia (PHN)? Learn about limited relief, risks, and why it isn't proven therapy.
THCV and Obesity: Promising Biology, Limited Human Evidence
THCV and obesity: limited human evidence, possible glycemic benefits, but not a proven weight-loss therapy; FDA has not approved cannabis for obesity.
Cannabis Hyperemesis Syndrome: Recognizing the Cycle of Vomiting and Relief
Discover cannabis hyperemesis syndrome (CHS): a cycle of nausea, vomiting, and relief linked to long-term cannabis use—diagnosis, risks, and recovery.